Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 6Colorectal Neoplasms 4Brain Neoplasms 3Radiodermatitis 2Pancreatic Neoplasms 2Pain, Postoperative 2Lung Neoplasms 2Leiomyoma 2Head and Neck Neoplasms 2Warts 1Surgical Wound 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Diseases 1Sigmoid Neoplasms 1Severe Acute Respiratory Syndrome 1Sarcoma 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroinflammatory Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Mastocytosis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Injury 1Locally Advanced Cervical Cancer 1Limited Stage Small Cell Lung Cancer 1Leukemia, Myeloid, Acute 1

Interventions

Sodium Chloride 1Saline Solution 1Mn-PyC3A 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroinflammatory Diseases × Sodium Chloride × 1 year × Clear all
NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Aristotle University Of Thessaloniki

Phase 4 Completed
56 enrolled
CNS

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡